- Home
- PASG vs ANEB Comparison
PASG vs ANEB Comparison
Compare PASG & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PASG
- ANEB
- Stock Information
- Founded
- PASG 2017
- ANEB 2020
- Country
- PASG United States
- ANEB United States
- Employees
- PASG N/A
- ANEB N/A
- Industry
- PASG Biotechnology: Pharmaceutical Preparations
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- PASG Health Care
- ANEB Health Care
- Exchange
- PASG Nasdaq
- ANEB Nasdaq
- Market Cap
- PASG 42.2M
- ANEB 36.7M
- IPO Year
- PASG 2020
- ANEB 2021
- Fundamental
- Price
- PASG $0.60
- ANEB $1.59
- Analyst Decision
- PASG Strong Buy
- ANEB Buy
- Analyst Count
- PASG 3
- ANEB 1
- Target Price
- PASG $8.00
- ANEB $8.00
- AVG Volume (30 Days)
- PASG 886.7K
- ANEB 70.0K
- Earning Date
- PASG 03-03-2025
- ANEB 02-11-2025
- Dividend Yield
- PASG N/A
- ANEB N/A
- EPS Growth
- PASG N/A
- ANEB N/A
- EPS
- PASG N/A
- ANEB N/A
- Revenue
- PASG N/A
- ANEB N/A
- Revenue This Year
- PASG N/A
- ANEB N/A
- Revenue Next Year
- PASG N/A
- ANEB N/A
- P/E Ratio
- PASG N/A
- ANEB N/A
- Revenue Growth
- PASG N/A
- ANEB N/A
- 52 Week Low
- PASG $0.45
- ANEB $0.80
- 52 Week High
- PASG $1.79
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- PASG 43.68
- ANEB 52.32
- Support Level
- PASG $0.56
- ANEB $1.56
- Resistance Level
- PASG $0.64
- ANEB $1.69
- Average True Range (ATR)
- PASG 0.11
- ANEB 0.14
- MACD
- PASG -0.01
- ANEB 0.01
- Stochastic Oscillator
- PASG 8.69
- ANEB 33.84
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.